ClinicalTrials.Veeva

Menu

The Standard Concentration of Morphine as a Positive Control for Intradermal Skin Test

C

Chulalongkorn University

Status

Completed

Conditions

Intradermal Test

Study type

Observational

Funder types

Other

Identifiers

NCT00853476
Chula-ARC 001/09

Details and patient eligibility

About

This study aims to compare skin reactivity results between morphine and histamine as a positive control agents in intradermal skin test.

Full description

Histamine hydrochloride and different concentrations of morphine sulfate will be intradermally injected and wheal diameter size will be comparatively measured between 15-30 minutes' time points after the test.

Enrollment

25 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18-60 years old

Exclusion criteria

  • immunodeficiency state
  • cancer
  • severe skin diseases
  • severe medical illnesses
  • malnutrition
  • uncontrolled asthma
  • pregnancy
  • received oral or systemic corticosteroid within 1 month before this study
  • receiving immunosuppressive agents
  • taken antihistamine within 3 days before this study
  • taking beta-blocker
  • previous history of immunotherapy
  • have hypersensitivity reaction to morphine/opiates

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems